Buppan P, Seethamchai S, Kuamsab N, Harnyuttanakorn P, Putaporntip C, Jongwutiwes S
Am J Trop Med Hyg. 2018; 99(4):987-994.
PMID: 30141388
PMC: 6159576.
DOI: 10.4269/ajtmh.18-0401.
van Schalkwyk D, Burrow R, Henriques G, Gadalla N, Beshir K, Hasford C
Malar J. 2013; 12:320.
PMID: 24028570
PMC: 3847303.
DOI: 10.1186/1475-2875-12-320.
Galle J, Attioua B, Kaiser M, Rusig A, Lobstein A, Vonthron-Senecheau C
Mar Drugs. 2013; 11(3):599-610.
PMID: 23442789
PMC: 3705360.
DOI: 10.3390/md11030599.
Ding X, Ubben D, Wells T
Malar J. 2012; 11:292.
PMID: 22913649
PMC: 3478971.
DOI: 10.1186/1475-2875-11-292.
Vonthron-Senecheau C, Kaiser M, Devambez I, Vastel A, Mussio I, Rusig A
Mar Drugs. 2011; 9(6):922-933.
PMID: 21747738
PMC: 3131551.
DOI: 10.3390/md9060922.
Removal of heterologous sequences from Plasmodium falciparum mutants using FLPe-recombinase.
van Schaijk B, Vos M, Janse C, Sauerwein R, Khan S
PLoS One. 2010; 5(11):e15121.
PMID: 21152048
PMC: 2994908.
DOI: 10.1371/journal.pone.0015121.
Spirotetrahydro beta-carbolines (spiroindolones): a new class of potent and orally efficacious compounds for the treatment of malaria.
Yeung B, Zou B, Rottmann M, Lakshminarayana S, Ang S, Leong S
J Med Chem. 2010; 53(14):5155-64.
PMID: 20568778
PMC: 6996867.
DOI: 10.1021/jm100410f.
Comparative transcriptional and genomic analysis of Plasmodium falciparum field isolates.
Mackinnon M, Li J, Mok S, Kortok M, Marsh K, Preiser P
PLoS Pathog. 2009; 5(10):e1000644.
PMID: 19898609
PMC: 2764095.
DOI: 10.1371/journal.ppat.1000644.
First assessment in humans of the safety, tolerability, pharmacokinetics, and ex vivo pharmacodynamic antimalarial activity of the new artemisinin derivative artemisone.
Nagelschmitz J, Voith B, Wensing G, Roemer A, Fugmann B, Haynes R
Antimicrob Agents Chemother. 2008; 52(9):3085-91.
PMID: 18559649
PMC: 2533467.
DOI: 10.1128/AAC.01585-07.
An improved and highly sensitive microfluorimetric method for assessing susceptibility of Plasmodium falciparum to antimalarial drugs in vitro.
Quashie N, de Koning H, Ranford-Cartwright L
Malar J. 2006; 5:95.
PMID: 17076900
PMC: 1657019.
DOI: 10.1186/1475-2875-5-95.
Targeting of hematin by the antimalarial pyronaridine.
Auparakkitanon S, Chapoomram S, Kuaha K, Chirachariyavej T, Wilairat P
Antimicrob Agents Chemother. 2006; 50(6):2197-200.
PMID: 16723583
PMC: 1479140.
DOI: 10.1128/AAC.00119-06.
Analysis of P-glycoprotein expression in purified parasite plasma membrane and food vacuole from Plasmodium falciparum.
Elandaloussi L, Lindt M, Collins M, Smith P
Parasitol Res. 2006; 99(6):631-7.
PMID: 16710674
DOI: 10.1007/s00436-006-0209-9.
Plasmodium falciparum parasites expressing pregnancy-specific variant surface antigens adhere strongly to the choriocarcinoma cell line BeWo.
Haase R, Megnekou R, Lundquist M, Ofori M, Hviid L, Staalsoe T
Infect Immun. 2006; 74(5):3035-8.
PMID: 16622246
PMC: 1459756.
DOI: 10.1128/IAI.74.5.3035-3038.2006.
Plasmodium falciparum merozoite surface protein 6 is a dimorphic antigen.
Pearce J, Triglia T, Hodder A, Jackson D, Cowman A, Anders R
Infect Immun. 2004; 72(4):2321-8.
PMID: 15039357
PMC: 375173.
DOI: 10.1128/IAI.72.4.2321-2328.2004.
Antimalarial 9-anilinoacridine compounds directed at hematin.
Auparakkitanon S, Noonpakdee W, Ralph R, Denny W, Wilairat P
Antimicrob Agents Chemother. 2003; 47(12):3708-12.
PMID: 14638470
PMC: 296215.
DOI: 10.1128/AAC.47.12.3708-3712.2003.
Validation of the hexose transporter of Plasmodium falciparum as a novel drug target.
Joet T, Eckstein-Ludwig U, Morin C, Krishna S
Proc Natl Acad Sci U S A. 2003; 100(13):7476-9.
PMID: 12792024
PMC: 164611.
DOI: 10.1073/pnas.1330865100.
Different mutation patterns of atovaquone resistance to Plasmodium falciparum in vitro and in vivo: rapid detection of codon 268 polymorphisms in the cytochrome b as potential in vivo resistance marker.
Schwobel B, Alifrangis M, Salanti A, Jelinek T
Malar J. 2003; 2:5.
PMID: 12665429
PMC: 152655.
DOI: 10.1186/1475-2875-2-5.
Rhoptry-associated protein 1-binding monoclonal antibody raised against a heterologous peptide sequence inhibits Plasmodium falciparum growth in vitro.
Moreno R, Poltl-Frank F, Stuber D, Matile H, Mutz M, Weiss N
Infect Immun. 2001; 69(4):2558-68.
PMID: 11254620
PMC: 98192.
DOI: 10.1128/IAI.69.4.2558-2568.2001.
Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site.
Korsinczky M, Chen N, Kotecka B, Saul A, Rieckmann K, Cheng Q
Antimicrob Agents Chemother. 2000; 44(8):2100-8.
PMID: 10898682
PMC: 90020.
DOI: 10.1128/AAC.44.8.2100-2108.2000.
Antigenicity of recombinant proteins derived from rhoptry-associated protein 1 of Plasmodium falciparum.
Fonjungo P, Stuber D, McBride J
Infect Immun. 1998; 66(3):1037-44.
PMID: 9488393
PMC: 108013.
DOI: 10.1128/IAI.66.3.1037-1044.1998.